Literature DB >> 30607758

Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP).

B E Meyerson1,2, P C Dinh3,4, J D Agley3,5,6, B J Hill7,8, D N Motley7, G A Carter9, W Jayawardene3,5,6, P T Ryder10.   

Abstract

To identify factors associated with pharmacist dispensing practice and comfort counseling patients about pre-exposure prophylaxis for HIV prevention (PrEP). Cross-sectional 2016 census of Indiana managing pharmacists measured PrEP awareness, comfort dispensing and counseling patients. Modified Poisson models with robust error variance estimated relative risks and confidence intervals. 15.8% of 284 pharmacists had dispensed PrEP and 11.6% had consulted about it. Dispensing and comfort counseling were associated with confidence in knowledge about PrEP medication adherence and adverse effects of PrEP medication; awareness about PrEP before the survey, number of full time pharmacists in their pharmacy, and increases in new HIV cases from 2015 to 2016 in communities served. Comfort counseling about PrEP was associated with the belief that pharmacists can be an important resource for HIV and HCV treatment.

Entities:  

Keywords:  HIV prevention; Pharmacist; Pharmacy practice; PrEP

Mesh：

Year:  2019        PMID： 30607758      PMCID： PMC8274484          DOI： 10.1007/s10461-018-02383-7

Source DB:  PubMed          Journal:  AIDS Behav        ISSN： 1090-7165


  44 in total

Review 1.  HIV transmission rates from persons living with HIV who are aware and unaware of their infection.

Authors:  H Irene Hall; David R Holtgrave; Catherine Maulsby
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

2.  Exploring Patterns of Awareness and Use of HIV Pre-Exposure Prophylaxis Among Young Men Who Have Sex with Men.

Authors:  Benjamin B Strauss; George J Greene; Gregory Phillips; Ramona Bhatia; Krystal Madkins; Jeffrey T Parsons; Brian Mustanski
Journal:  AIDS Behav       Date:  2017-05

3.  PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists.

Authors:  Andrew E Petroll; Jennifer L Walsh; Jill L Owczarzak; Timothy L McAuliffe; Laura M Bogart; Jeffrey A Kelly
Journal:  AIDS Behav       Date:  2017-05

4.  The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.

Authors:  Aaron J Siegler; Farah Mouhanna; Robertino Mera Giler; Kevin Weiss; Elizabeth Pembleton; Jodie Guest; Jeb Jones; Amanda Castel; Howa Yeung; Michael Kramer; Scott McCallister; Patrick S Sullivan
Journal:  Ann Epidemiol       Date:  2018-06-15       Impact factor: 3.797

5.  Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state.

Authors:  Elizabeth J Unni; Nadia Lian; William Kuykendall
Journal:  J Am Pharm Assoc (2003)       Date:  2016 Sep-Oct

Review 6.  Pharmacists as providers of HIV pre-exposure prophylaxis.

Authors:  Christine Bruno; Parya Saberi
Journal:  Int J Clin Pharm       Date:  2012-10-17

7.  The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access.

Authors:  Sarah K Calabrese; Valerie A Earnshaw; Kristen Underhill; Nathan B Hansen; John F Dovidio
Journal:  AIDS Behav       Date:  2014-02

Review 8.  Public health in community pharmacy: a systematic review of pharmacist and consumer views.

Authors:  Claire E Eades; Jill S Ferguson; Ronan E O'Carroll
Journal:  BMC Public Health       Date:  2011-07-21       Impact factor: 3.295

Review 9.  Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation.

Authors:  Tamara J Brown; Adam Todd; Claire O'Malley; Helen J Moore; Andrew K Husband; Clare Bambra; Adetayo Kasim; Falko F Sniehotta; Liz Steed; Sarah Smith; Lucie Nield; Carolyn D Summerbell
Journal:  BMJ Open       Date:  2016-02-29       Impact factor: 2.692

10.  Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementation.

Authors:  Ian Ross; Carlos Mejia; Johanna Melendez; Philip A Chan; Amy C Nunn; William Powderly; Katherine Goodenberger; Jingxia Liu; Kenneth H Mayer; Rupa R Patel
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240
View more
  4 in total

1.  Attitudes about community pharmacy access to HIV prevention medications in California.

Authors:  Kimberly A Koester; Parya Saberi; Shannon M Fuller; Emily A Arnold; Wayne T Steward
Journal:  J Am Pharm Assoc (2003)       Date:  2020-07-12

2.  I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.

Authors:  Beth E Meyerson; Carrie A Lawrence; Summer Dawn Cope; Steven Levin; Christopher Thomas; Lori Ann Eldridge; Haley B Coles; Nina Vadiei; Amy Kennedy
Journal:  Harm Reduct J       Date:  2019-09-18

3.  Expanding Knowledge About Implementation of Pre-exposure Prophylaxis (PrEP): A Methodological Review.

Authors:  Rogério M Pinto; Ashley Lacombe-Duncan; Emma Sophia Kay; Kathryn R Berringer
Journal:  AIDS Behav       Date:  2019-10

Review 4.  Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review.

Authors:  Alice Zhao; Derek T Dangerfield; Amy Nunn; Rupa Patel; Jason E Farley; Chinenye C Ugoji; Lorraine T Dean
Journal:  AIDS Behav       Date:  2021-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.